COMPASS Pathways plc On December 5, 2023, the board of directors of company appointed Teri Loxam as chief financial officer, principal financial officer and principal accounting officer, effective as of the later of March 1, 2024 or the filing of the Company?s annual report for the period ending December 31, 2023 (the ?Effective Date?). Ms. Loxam will serve as an advisor during the period leading up to her appointment as chief financial officer. Mary-Rose Hughes will continue to serve as interim chief financial officer, principal financial officer and principal accounting officer until the Effective Date.

Teri Loxam, age 51, has over 20 years of experience in the pharmaceutical and biotechnology sectors with diverse roles spanning strategy, investor relations, finance, and communications. Ms. Loxam served as Chief Financial Officer of Gameto Inc., a privately held, clinical-stage biotechnology company from April 2023 until October 2023. Previously, Ms. Loxam served as Chief Financial Officer and Chief Operating Officer of Kira Pharmaceuticals, a privately held, clinical-stage biotechnology company, from November 2021 to April 2023 and as Chief Financial Officer of SQZ Biotechnologies, from August 2019 to November 2021.

From August 2015 to August 2019, Ms. Loxam served in various roles at Merck & Co. Inc., including serving as Senior Vice President of Investor Relations and Global Communications. Before that, from July 2012 to August 2015, Ms. Loxam served as Vice President of Investor Relations at IMAX Corporation.

From June 2001 to July 2012, Ms. Loxam had a number of roles of increasing responsibility across Strategy, Treasury and Investor Relations at Bristol-Myers Squibb. Ms. Loxam currently serves on the boards of directors and as audit committee chairperson at Cardiol Therapeutics Inc. where she has served since May 2022 and Vaxcyte Inc. where she has served since September 2021. Ms. Loxam holds an M.B.A. from the University of California, Irvine, Paul Merage School of Business, and a B.Sc.

from the University of Victoria.